Ogawa Richard's Form 4 filing
Palomino Laboratories Inc. (PALX) · filed Oct 9, 2025
- Accession no.
- 0001493152-25-017571
- Filed
- Oct 9, 2025
- Trade date
- Sep 29, 2025
- Filing delay
- 10 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 1 derivative transaction. It was filed 10 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ogawa RichardCIK 0001568078 | Director, Officer (Secretary) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 29, 2025 | Common Stock | JOtherAcquired | +1,625,000 | – | – | 1,750,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 29, 2025 | Common Stock | SSaleAcquired | +125,000 | $1.20 | +$150,000 | 125,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.